Trial intelligence / Profile preview

NexoBrid vs SOC in Children with Thermal Burns

NCT02278718Phase 3Completed

Sponsor
MediWound
Start
May 2015
Primary completion
Apr 2021
Modality
Replacement Enzymes
Countries
14
01

Overview

A Phase 3 trial of anacaulase-bcdb in thermal burn, sponsored by MediWound. Started May 2015; status: completed.

02

Drugs

anacaulase-bcdb
03

Conditions

thermal burn

Beyond the preview

Go deeper on NCT02278718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02278718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call